Paradromics

Paradromics CEO Matt Angle recently joined Lumafield's Go/No-Go podcast to talk about building the world's highest data rate brain-computer interface (BCI) and the early moments that shaped our trajectory. Listen to hear Matt break down how the Connexus® BCI system works, why device longevity is the defining design challenge in implantable neurotechnology, and what it means that the first people to use speech prostheses will be querying AI directly from their brain. Link in comments.

Without the ability to get data in and out of the brain reliably, a camera is just a camera and a robotic arm is just a robot. With a brain-computer interface (BCI), they can become eyes and arms. People should never lose their voice, and mental health should never be guesswork. As BCIs make the brain more accessible for healing, the realm of possibilities will expand. Read the full interview at the link in the comments, where Matt explores how we're working to create a true interface between biology and technology.   Thanks to the team at LSI Europe for the conversation.   #BCI #NeuralEngineering #DeepTech

Last week, our team had the honor of participating in the 2026 Under Ballou Skies Golf Classic in support of the ALS community. Events like this bring together families, clinicians, and advocates all working toward the same goal: better outcomes, more options, and reminding those living with ALS that they are not alone. As a team working to expand communication options for people living with ALS, being part of this community matters deeply to us. Thank you to the organizers, participants, and everyone who gave their time and presence. If you or someone you know is living with ALS and wants to explore emerging opportunities, the Connect-One Clinical Study is now enrolling. Find more information at the link in the caption. Mea Amor | Paras Patel, PhD | Donald Savacool III | Kelsea Marshall | Ken Walker | Marilee Bodden | Bryan Kerr | Mario Rodriguez #ALSAwareness #Neurotechnology

China recently approved a world-first brain-computer interface (BCI), but what does this approval actually mean for U.S. companies and overall policy? The reality is nuanced, and our latest blog breaks it down: what was actually approved, what the NEO system actually does, and how we can all learn from China’s regulatory and government-aligned playbook to build a stronger path to commercialization in the U.S. Read more at the link in the comments. #BrainComputerInterface #BCI #Neurotech #ChinaTech #HealthcarePolicy 

Paradromics CEO Matt Angle and our VP of Capital Formation & Strategy Justin S. recently traveled to Asia to connect with investors and collaborators who share our vision: using advanced brain-computer interface technology to build a world where living with impairment no longer means inability. #braincomputerinterface #neurotech

Our clinical trial is now live, coast-to-coast! We're proud to share that all three Connect-One clinical study sites – University of California, Davis, Massachusetts General Hospital, and University of Michigan – are open and recruiting. The road to restoring communication runs through all of them. Learn more about Connect-One at the link in the comments.

The idea that all brain-computer interfaces (BCIs) require new specialized equipment or unfamiliar novel surgical techniques is a common misconception. Connexus® BCI builds on nearly 30 years of BCI research and is grounded in surgical techniques every neurosurgeon already knows – skills used daily for deep brain stimulators, implantable pulse generators, and other well-validated devices with well-documented clinical safety. No new surgical capital. No unfamiliar procedures. No steep learning curve. This means any neurosurgeon can be trained to implant Connexus confidently and safely, shortening the path to patients, and hospitals don't need to overhaul their infrastructure to offer this treatment. Proven technique. Familiar technology. Broader access. Learn more about the "why" behind our device design at the link in the comments.

Paradromics CEO Matt Angle recently took to Zurich for WORLD.MINDS: a conference that brings together some of the most curious, rigorous thinkers across science, business, and the arts. The question he hears the most from audiences like these isn't "Can you do it?" it's "How far will this go?" The discussion surrounding BCI capabilities is no longer hypothetical, and future applications will extend far beyond what most people realize. Thank you again to the team at World.Minds for inviting us to be part of the conversation.